National Institute of blood disease and bone marrow transplant

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Thalassemia Major, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia	Recruiting	Phase 2	2025-05-30		NCT06490627
Long Term Beta Thalassemia Treatment: Findings From The Extension Period	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia	Active, not recruiting	Phase 2	2025-05-30		NCT06490601

Clinical trials